In Practice: EOIs to join ATAGI Australia’s immunisation advisory group is seeking applications for new members to provide advice to the Federal Health Minister.
‘Life-changing’ eczema drug to stay on PBS Dupixent was at high risk of coming off the PBS as soon as this month due to high demand, but negotiations have secured its continued listing.
DoHAC details vitamin B12 testing changes The Department has further revealed what will change when it amends vitamin B12 testing and urine examination MBS items next year.
Calls to delay changes to B12 testing Potential changes to item descriptors, fees and claim frequencies are scheduled for July, but doctors are calling for further consultation, saying ‘additional red tape for GPs should be avoided’.
Endometriosis drug Visanne added to PBS Doctors have described dienogest as ‘miraculous’, with its listing expected to positively impact up to 500,000 patients.
New Chair for RACGP Funding and Health System Reform Associate Professor Rashmi Sharma is stepping up at a ‘pivotal moment for the profession’ and has shared her goals for the future.
‘Unprecedented’ demand on PBAC forces extra meeting Its capacity has been exceeded by a ‘huge pipeline of new medicines’, after companies put forward a record number of submissions.
Medicare watchdog repayments soar by $10m The PSR recouped $32 million from negotiated agreements and determinations last year, often through doctors’ ‘lack of clinical input and poor record keeping’.
Final Review of General Practice Incentives report revealed It recommends a suite of changes which, if accepted, would see GPs’ incentives undergo a major shakeup, including a new payment architecture and a shift in the foundation of general practice.
Action taken amid continuing PrEP shortage As supply of the HIV prevention medication continues to be disrupted, the Federal Government has listed a US brand on the PBS to shore up access.